
Maharashtra FDA Commissioner Tukaram Mundhe wrote to the Department of Pharmaceuticals and the NPPA, recommending guidelines on the gap between trade procurement prices and MRPs.
A state survey revealed massive markups, including an IV infusion set procured at ₹11.05 with an MRP of ₹325 and a syringe procured at ₹6.75 with an MRP of ₹57.20.
Mr. Mundhe noted that unlike scheduled medicines under the Drugs Prices Control Order, most medical devices and consumables remain unmonitored.